01 Dec 2015
Aurobindo PharmaBSE 1.80 % has confirmed that it has received final approval from USFDA to manufacture and market generic version of Risedronate Sodium tablets, used in the treatment of osteoporosis, in the American market.
Economic Times
Call for nominations for Awards Committee Chair
30 Oct 2024
James M Tanner Award - 2025 nominations open
30 Oct 2024
Would you like to host the BSPED annual meeting?
21 Oct 2024